Ten neurodegenerative diseases (Huntington's disease; spinocerebellar ataxia (SCA) types 1, 2, 3, 6, 7, 8 and 12; dentatorubral-pallidoluysian atrophy; and spinal and bulbar muscular atrophy) are now known to be caused by expansions of CAG/CTG trinucleotide repeats. The P.I. hypothesizes that similar disorders, including other forms of spinocerebellar ataxia, familial spastic paraplegia, and some types of familial Parkinsonism, may also be caused by expansions of CAG/CTG repeats. He proposes a three-part plan to test this hypothesis. First, the P.I. will search the genomes of subjects with progressive neurodegenerative disorders of unknown etiology with an assay (known as repeat expansion detection, or RED) that enables identification of long CAG/CTG repeat expansions. Expansions detected by this method will be cloned, along with flanking sequence, and they will develop PCR-based assays to search for the expansions in other subjects. Secondly, they will develop a catalogue of CAG/CTG repeats in the human genome. This will be accomplished by systematic searches of the genetic data banks, supplemented by cloning efforts in the P.I.'s laboratory in collaboration with Life Technologies, Inc. They will determine the reading frame (if any) of each repeat, localize each repeat to a chromosomal locus, develop a PCR assay for testing the length of each repeat, and place this information on a publicly accessible Web site. The P.I. and an extensive group of collaborators will use these assays to test for expansions of specific repeats in subjects and controls. Third, the P.I. will undertake preliminary mechanistic studies of novel expansion mutations, including determination of whether the expansion is transcribed and translated and the effect of the expansion on gene expression. Overall, the proposed experiments will enable a systematic test for CAG/CTG expansion mutations in a variety of devastating neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS038054-03
Application #
6540031
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Gwinn, Katrina
Project Start
2000-05-15
Project End
2005-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
3
Fiscal Year
2002
Total Cost
$367,875
Indirect Cost
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Rudnicki, Dobrila D; Pletnikova, Olga; Vonsattel, Jean-Paul G et al. (2008) A comparison of huntington disease and huntington disease-like 2 neuropathology. J Neuropathol Exp Neurol 67:366-74
Rudnicki, Dobrila D; Holmes, Susan E; Lin, Mark W et al. (2007) Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci. Ann Neurol 61:272-82
Holmes, S E; Wentzell, J S; Seixas, A I et al. (2006) A novel trinucleotide repeat expansion at chromosome 3q26.2 identified by a CAG/CTG repeat expansion detection array. Hum Genet 120:193-200
Seixas, Ana I; Maurer, Martin H; Lin, Mark et al. (2005) FXTAS, SCA10, and SCA17 in American patients with movement disorders. Am J Med Genet A 136:87-9
Liszewski, Christine M; O'Hearn, Elizabeth; Leroi, Iracema et al. (2004) Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration. J Neuropsychiatry Clin Neurosci 16:109-12
Nicholas, Anthony P; O'Hearn, Elizabeth; Holmes, Susan E et al. (2004) Clinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation. Mov Disord 19:641-8
Margolis, Russell L; Holmes, Susan E; Rosenblatt, Adam et al. (2004) Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol 56:670-4
Rudnicki, Dobrila D; Margolis, Russell L (2003) Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversy. Expert Rev Mol Med 5:1-24
Margolis, Russell L (2003) Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future. Expert Rev Mol Diagn 3:715-32
Margolis, Russell L; Ross, Christopher A (2003) Diagnosis of Huntington disease. Clin Chem 49:1726-32

Showing the most recent 10 out of 17 publications